Key result
Updated KDIGO heat map stratifies patient risk using eGFR and albuminuria to guide early management.
Why the study?
Real-world adoption of the updated KDIGO heat map remains limited despite its utility for risk stratification in chronic kidney and cardiovascular disease.
This review highlights the updated KDIGO heat map for stratifying chronic kidney disease risk and provides an approach for its implementation in primary care.
May facilitate earlier CKD detection via KDIGO stratification in primary care; leaves open real-world adoption and outcome impact.
The increasing prevalence of type 2 diabetes is contributing substantially to chronic kidney and cardiovascular disease. The updated Kidney Disease: Improving Global Outcomes (KDIGO) heat map provides a practical framework for stratifying patient risk, using estimated glomerular filtration rate (eGFR) and albuminuria to facilitate early detection and evidence-based management. However, real-world adoption of the heat map remains limited. Integrating this tool into primary care and other subspecialities beyond nephrology can enhance individualized care. This review highlights the KDIGO guideline updates and provides an approach to implementing the heat map in primary care.
No takes yet. Share an insight, caveat, or question.
Galindo et al. (2026) conducted a review in Chronic kidney disease and type 2 diabetes. KDIGO heat map was evaluated. The updated KDIGO heat map provides a practical framework for stratifying patient risk using eGFR and albuminuria to facilitate early detection and evidence-based management in primary care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: